赛隆药业
(002898)
| 流通市值：10.74亿 | | | 总市值：18.67亿 |
| 流通股本：1.01亿 | | | 总股本：1.76亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 56,544,816.92 | 87,118,672.26 | 22,874,071.13 | 58,679,132.33 |
| 应收票据及应收账款 | 65,966,038.83 | 44,069,802.13 | 43,069,227.66 | 64,320,092.37 |
| 其中：应收票据 | 17,936,960.4 | 15,679,598.91 | 13,529,760.27 | 17,081,562.27 |
| 应收账款 | 48,029,078.43 | 28,390,203.22 | 29,539,467.39 | 47,238,530.1 |
| 应收款项融资 | 9,783,336.67 | 11,202,134.68 | 16,257,520 | 19,652,333.43 |
| 预付款项 | 7,616,124.14 | 4,297,382.33 | 5,995,561.58 | 6,285,920.83 |
| 其他应收款合计 | 7,259,187.06 | 10,725,320.45 | 16,723,766.32 | 16,961,654.9 |
| 存货 | 79,231,200 | 88,871,523.55 | 93,897,239.18 | 93,075,309.48 |
| 一年内到期的非流动资产 | - | 0 | - | - |
| 其他流动资产 | 2,556,337.87 | 4,768,613.12 | 2,549,641.2 | 1,794,930.04 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 231,100,641.49 | 256,302,322.01 | 231,367,027.07 | 275,769,373.38 |
| 非流动资产: | | | | |
| 长期应收款 | 1,519,634.92 | 1,546,566.89 | - | - |
| 其他非流动金融资产 | 69,856,009.4 | 69,856,009.4 | 69,410,342.76 | 66,510,186.54 |
| 投资性房地产 | 18,776,484.04 | 18,797,402.98 | 14,535,721.81 | 14,613,214.66 |
| 固定资产 | 343,726,003.74 | 350,245,600.44 | 371,404,686.01 | 378,363,773.8 |
| 在建工程 | 2,689,790.72 | 1,435,946.7 | 5,950,946.4 | 3,572,405.9 |
| 使用权资产 | 343,505.88 | 427,778.2 | 288,411.5 | 274,636.51 |
| 无形资产 | 68,924,816.38 | 66,996,057.83 | 64,817,361.98 | 65,796,125.16 |
| 开发支出 | 44,999,335.15 | 45,736,772.18 | 41,710,399.22 | 38,543,202.35 |
| 商誉 | - | 0 | - | - |
| 长期待摊费用 | - | 0 | - | - |
| 递延所得税资产 | 1,584,426.87 | 1,959,876.16 | 8,833,462.38 | 10,825,158.4 |
| 其他非流动资产 | 787,095.45 | 539,241.56 | 4,313,223.66 | 2,943,846.6 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 553,207,102.55 | 557,541,252.34 | 581,264,555.72 | 581,442,549.92 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 784,307,744.04 | 813,843,574.35 | 812,631,582.79 | 857,211,923.3 |
| 流动负债: | | | | |
| 短期借款 | 80,013,097.16 | 90,047,819.38 | 70,000,000 | 80,000,000 |
| 应付票据及应付账款 | 52,170,419.68 | 63,528,990.71 | 80,650,626.43 | 102,840,406.79 |
| 其中：应付票据 | - | - | 6,579,033.49 | 8,422,007.49 |
| 应付账款 | 52,170,419.68 | 63,528,990.71 | 74,071,592.94 | 94,418,399.3 |
| 预收款项 | - | 100,000 | 25,288.15 | 12,847.81 |
| 合同负债 | 10,257,549.94 | 11,531,575.51 | 11,388,189.86 | 24,588,522.2 |
| 应付职工薪酬 | 8,647,626.96 | 8,438,796.17 | 9,386,129.98 | 7,073,050.75 |
| 应交税费 | 2,640,514.94 | 4,940,923.96 | 2,315,933.28 | 4,619,515.68 |
| 其他应付款合计 | 9,912,390.44 | 12,572,658.79 | 14,033,988.15 | 11,047,623.58 |
| 一年内到期的非流动负债 | 24,355,183.68 | 21,957,345.13 | 21,664,555.4 | 22,975,605.07 |
| 其他流动负债 | 12,224,218.45 | 13,892,094.37 | 12,924,559.72 | 14,668,905.38 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 200,221,001.25 | 227,010,204.02 | 222,389,270.97 | 267,826,477.26 |
| 非流动负债: | | | | |
| 长期借款 | 22,840,000 | 25,080,000 | 30,500,000 | 31,000,000 |
| 租赁负债 | 37,941.79 | 37,976.18 | 738,144.33 | 83,594.51 |
| 长期应付款 | 11,162,222.45 | 13,232,338.09 | 15,752,486.93 | 16,761,290.45 |
| 预计负债 | - | 0 | - | - |
| 递延收益 | 2,781,098.67 | 2,841,666.84 | 2,902,235.01 | 2,962,803.18 |
| 递延所得税负债 | 9,759,704.31 | 9,759,704.31 | 9,676,551.41 | 9,241,527.98 |
| 其他非流动负债 | - | 0 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 46,580,967.22 | 50,951,685.42 | 59,569,417.68 | 60,049,216.12 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 246,801,968.47 | 277,961,889.44 | 281,958,688.65 | 327,875,693.38 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 176,000,000 | 176,000,000 | 176,000,000 | 176,000,000 |
| 资本公积 | 288,469,403.58 | 288,469,403.58 | 288,469,403.58 | 288,469,403.58 |
| 盈余公积 | 18,009,717.23 | 18,009,717.23 | 17,076,787.1 | 17,076,787.1 |
| 未分配利润 | 55,026,654.76 | 53,402,564.1 | 49,126,703.46 | 47,790,039.24 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 537,505,775.57 | 535,881,684.91 | 530,672,894.14 | 529,336,229.92 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 537,505,775.57 | 535,881,684.91 | 530,672,894.14 | 529,336,229.92 |
| 负债和股东权益合计 | 784,307,744.04 | 813,843,574.35 | 812,631,582.79 | 857,211,923.3 |
| 公告日期 | 2024-04-20 | 2024-04-20 | 2023-10-26 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |